The development of the Nimbus/Pittsburgh axial flow LVAS shows promising early results in computational and in vivo models, including successful auto speed control.
Answers are grounded in this paper and cite their sources.
Supports nonlubricated bearing LVAD development in animals; leaves open human feasibility and safety.
Nimbus, Inc. and the University of Pittsburgh's School of Medicine have been collaborators developing rotary blood pump technology since 1992. Currently, a major focus is on an implantable left ventricular assist system (LVAS) that utilizes an electric powered axial flow blood pump. In addition to the blood pump, a major development item is the electronic controller and the control algorithm for modulating the pump speed in response to varying physiologic demands. Methods being used in developing the axial flow LVAS include the use of computational fluid dynamic modeling of the interior flow field of the pump, flow visualization of the flow field using laser based imaging, and computer simulation of blood pump-physiological interactions as well as an extensive in vivo test program. Results to date include successful in vivo tests of blood pumps with nonlubricated bearings and demonstrations of auto speed control using electrical current as the observable parameter.
No takes yet. Share an insight, caveat, or question.
Butler et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: